Ascendis Pharma A/S (ASND) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Scott Smith - Senior Vice President and CFO Jan Mikkelsen - President and CEO Jesper Hoiland - Global Chief Commercial Officer Dr. Dana Pizzuti - Head, Development Operations and CMO Dr. Juha Punnonen - Head, Oncology Conference Call Participants Jessica Fye - J.P. Morgan Michelle Gilson - Canaccord Genuity Josh Schimmer - Evercore Alethia Young - Cantor Joori Park - SVB Leerink Operator Good day an ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ OR ☐ SHELL COMPANY REPORT P ...

Ascendis Pharma A/S (ASND) Q3 2020 Earnings Conference Call November 11, 2020 4:30 PM ET Company Participants Scott Smith – Senior Vice President and Chief Financial Officer Jan Mikkelsen – President and Chief Executive Officer Mark Bach – Head-Clinical Development and Medical Affairs for Endocrinology Rare Diseases Jesper Høiland – Global Chief Commercial Officer Dana Pizzuti – Head-Development Operations Conference Call Participants Jessica Fye – JPMorgan Michelle Gilson – Canaccord Genuity Andrew Anido – ...

Ascendis Pharma A/S (ASND) Q2 2020 Earnings Conference Call August 27, 2020 4:30 PM ET Company Participants Scott Smith - CFO & SVP Jan Mikkelsen - President & CEO Dana Pizzuti - SVP, Development Operations Conference Call Participants Michelle Gilson - Canaccord Genuity Joori Park - SVB Leerink Joshua Schimmer - Evercore ISI Jessica Fye - JPMorgan Chase & Co. James Birchenough - Wells Fargo Securities Tazeen Ahmad - Bank of America Merrill Lynch Alethia Young - Cantor Fitzgerald & Co. Trevor Allred - Oppen ...

ascendis pharma Ascendis Pharma A/S Cautionary Note On Forward-Looking Statements This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, such as statements regarding our future results of operations and financial position, including our business strategy, prospective products, availability of funding, clinical trial results, product approvals and regulatory pathways, collaborations, licensing or other arrangements, the ...

Ascendis Pharma A/S (ASND) Q1 2020 Earnings Conference Call May 19, 2020 4:30 PM ET Company Participants Scott Smith - Senior Vice President and Chief Financial Officer Jan Mikkelsen - Chief Executive Officer Dana Pizzuti - Head, Development Operations Juha Punnonen - Head, Oncology Conference Call Participants Tazeen Ahmad - Bank of America Michelle Gilson - Canaccord David Lebowitz - Morgan Stanley Josh Schimmer - Evercore ISI Alethia Young - Cantor Fitzgerald Jim Birchenough - Wells Fargo Tiago Fauth - C ...

财务数据关键指标变化 - 2019年净亏损2.18亿欧元，包含非现金费用4,420万欧元[682] - 2019年股份支付费用为3750万欧元，2018年为1970万欧元，2017年为970万欧元[660] - 预付项目成本为580万欧元，应计项目成本为1050万欧元（2018年分别为1140万欧元和910万欧元）[669] - 商誉账面价值连续两年保持350万欧元（2019年及2018年）[668] 现金流表现 - 2019年经营活动现金流为-1.759亿欧元，较2018年的-1.388亿欧元有所恶化[681][682] - 2019年融资活动现金流为4.936亿欧元，主要来自3月后续公开发行净收益4.803亿欧元[681][687] - 2019年投资活动现金流为-515.9万欧元，主要用于德国和美国实验室设备购置[681][685] - 2018年融资活动现金流为2.033亿欧元，主要来自2月后续发行净收益1.969亿欧元[681][689] - 2017年融资活动现金流为1.247亿欧元，主要来自10月后续发行净收益1.231亿欧元[681][690] - 截至2019年底公司现金及等价物净增加3.125亿欧元[681] 融资活动 - 通过2019年3月完成的后续发行获得主要美元资金[638] - 公司通过多次公开募股和权证行权累计获得净收益约11.914亿欧元，包括首次公开募股、后续发行和权证行权[680] 现金及流动性管理 - 公司持有现金及现金等价物总额为5.981亿欧元[675] - 采用投资政策优先保障资本保全和流动性需求[641] - 公司无第三方计息债务[640][675] 外汇风险敞口 - 公司货币性资产和负债净账面金额为5.262亿欧元，其中4.515亿美元以美元计价[638] - 美元兑欧元升值10%将增加净利润和权益4780万欧元，贬值10%将产生同等幅度减少[639] 租赁及承诺事项 - 租赁合同增量借款利率：欧元/丹麦克朗合约2.25%-2.5%，美元合约4.25%-5.0%[674] - 公司租赁义务总额为4,355.2万欧元，其中1年内到期619.1万欧元[692] - 建设租赁改良工程承诺总额852.3万欧元，全部在1年内到期[692]

Ascendis Pharma A/S (ASND) Q4 2019 Earnings Conference Call April 1, 2020 4:30 PM ET Company Participants Scott Smith - Senior Vice President and Chief Financial Officer Jan Mikkelsen - President and Chief Executive Officer Tom Larson - Chief Commercial Officer Juha Punnonen - Head, Oncology Dana Pizzuti - Head, Development Operations Conference Call Participants Jessica Fye - JPMorgan Tazeen Ahmad - Bank of America Michelle Gilson - Canaccord Genuity David Lebowitz - Morgan Stanley Jim Birchenough - Wells ...